4.6 Review

New perspectives on PPAR, VDR and FXRα as new actors in testicular pathophysiology

期刊

MOLECULAR ASPECTS OF MEDICINE
卷 78, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.mam.2020.100886

关键词

-

资金

  1. Inserm, CNRS, Universite Clermont Auvergne
  2. French government IDEX-ISITE initiative [16-IDEX-0001]

向作者/读者索取更多资源

The study highlights the emerging roles of members of the nuclear receptor superfamily in male fertility disorders and discusses their potential as biomarkers or therapeutic targets for the management of fertility disorders.
The incidence of reproductive disorders is constantly increasing and affects 15% of couples, with male's abnormalities diagnosed in almost half of the cases. The male gonads exert two major functions of the testis with the productions of gametes (exocrine function) and of sexual hormones (endocrine function). In the last decades, next to steroid receptors such as estrogen and androgen receptors, the involvement of other members of the nuclear receptor superfamily have been described such as Steroidogenic factor-1 (SF-1), Nerve growth factor IB (NGFIB), Liver-X-Receptora (LXR alpha) and Dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX-1). The purpose of this review is to highlight the emerging roles of some members of the nuclear receptor superfamily among which the vitamin-D Receptor (VDR), Peroxisome Proliferator-Activated Receptor (PPAR), Farnesoid-X-Receptor-alpha (FXR alpha). We discuss how these receptors could participate to explain male fertility disorders; and their potential to be use as biomarkers or therapeutic targets for management of fertility disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据